Postdoc Research Associate Cancer Immunotherapy, 0094825
Full time Fixed term until July 2023
Three positions available for Research Associates to provide their research expertise in CAR T-Cells
Base Salary $79,784 - $107,516 + 17% superannuation
About the opportunity
The University of Sydney recently appointed Professor Cameron Turtle as the CLEARbridge Chair of Cancer Immunotherapy. Professor Turtle has recently returned to Australia from Seattle where he led clinical and laboratory research teams conducting multiple investigator-initiated phase 1 clinical trials of genetically modified cellular (CAR-T cell) immunotherapies for patients with haematologic malignancies.
The School of Medical Sciences in the Faculty of Medicine and Health has an exciting opportunity for 3 early career researchers to join a newly formed research team supporting the continuation of Professor Turtle’s work in Australia. The Research Associates will be running experiments with the aim of understanding the characteristics of distinct human T-Cell subsets, the development of novel tumor immunotherapies and factors governing the immune response to cancer.
Your key responsibilities will be to:
· carry out relevant lab based research
· supervise and mentor research support staff and students
· assist with various research support requirements
· collaborate with research teams to prepare research findings for publication.
Closing date for applications 11.59pm, 12 October 2022
Please click here to apply Postdoctoral Research Associate Cancer Immunotherapy 0094825
For more information click here
Haematology Society of Australia and New Zealand (HSANZ)
145 Macquarie Street, Sydney NSW 2000
Tel: 02 8097 8114
Copyright © 2020 Haematology Society of Australia & New Zealand (HSANZ). All Rights Reserved.